NUCLEAI
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
NUCLEAI
Industry:
Artificial Intelligence Health Care Machine Learning
Founded:
2017-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.nucleaimd.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
46.5 M USD
Technology used in webpage:
SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Amazon IPv6 Google Apps For Business Cloudflare Hosting
Similar Organizations
mfine
Mfine is a health-tech startup developing an AI-powered telemedicine mobile app.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Neteera
Neteera developed an AI-powered sensing platform to reduce treatment failures & improve outcomes in health screening, diagnosis & treatment.
TuSimple
TuSimple is a self-driving truck company developing technology that allows them to drive from depot-to-depot without human intervention.
Visit
AI driven chatbot to provide health advice within minutes.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fosun RZ Capital
Fosun RZ Capital investment in Series B - Nucleai
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series B - Nucleai
Grove Ventures
Grove Ventures investment in Series B - Nucleai
Vertex Ventures Israel
Vertex Ventures Israel investment in Series B - Nucleai
Section 32
Section 32 investment in Series B - Nucleai
Sanofi Ventures
Sanofi Ventures investment in Series B - Nucleai
Vertex Ventures Israel
Vertex Ventures Israel investment in Series A - Nucleai
Grove Ventures
Grove Ventures investment in Series A - Nucleai
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series A - Nucleai
Grove Ventures
Grove Ventures investment in Seed Round - Nucleai
Official Site Inspections
http://www.nucleaimd.com
- Host name: cloudproxy10179.sucuri.net
- IP address: 192.124.249.179
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
